<DOC>
<DOCNO>
EP-0000336
</DOCNO>
<TEXT>
<DATE>
19790124
</DATE>
<IPC-CLASSIFICATIONS>
C07D-239/48 C07D-239/49 C07D-239/00 <main>C07D-239/48</main> C07D-403/12 C07D-403/00 C07D-405/00 C07D-413/12 A61K-31/505 C07D-401/12 C07D-405/12 
</IPC-CLASSIFICATIONS>
<TITLE>
n-benzylpyrimidinyl-amidines, process for their preparation and medicines containing them.
</TITLE>
<APPLICANT>
basf agde<sep>basf aktiengesellschaft<sep>basf aktiengesellschaftcarl-bosch-strasse 3867063 ludwigshafende<sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
gutsche klaus dr <sep>kohlmann wilhelm dr<sep>kroemer gerd dr  <sep>scharwaechter peter dr<sep>gutsche, klaus, dr.<sep>kohlmann, wilhelm, dr.<sep>kroemer, gerd, dr.<sep>scharwaechter, peter, dr.<sep>gutsche, klaus, dr.ehmschenkamp 5d-2084 rellingende<sep>kohlmann, wilhelm, dr.an der duene 6d-2082 moorregede<sep>kroemer, gerd, dr.verstorben, zuletzt wohnhaft in kaltenweide 100ad-2200 elmshornde<sep>scharwaechter, peter, dr.klinkerstrasse 26d-2082 moorregede<sep>gutsche, klaus, dr. <sep>kohlmann, wilhelm, dr.<sep>kroemer, gerd, dr.  <sep>scharwaechter, peter, dr.<sep>gutsche, klaus, dr.ehmschenkamp 5d-2084 rellingende<sep>kohlmann, wilhelm, dr.an der duene 6d-2082 moorregede<sep>kroemer, gerd, dr.verstorben, zuletzt wohnhaft in kaltenweide 100ad-2200 elmshornde<sep>scharwaechter, peter, dr.klinkerstrasse 26d-2082 moorregede<sep>
</INVENTOR>
<ABSTRACT>
1.  amidino-benzylpyrimidines of the general formula i  see diagramm : ep0000336,p9,f1  where r**1 , r**2 , and r**3 , which may be identical or different, are hydrogen, methyl, methoxy or chlorine, r**4 is alkyl of 1 to 6 carbon atoms or benzyl and r**5 and r**6 , which may be identical or different, are hydrogen, lower alkyl of 1 to 4 carbon atoms, trimethoxybenzyl, benzyl or phenyl, cyclohexyl, adamantyl or furfuryl, or one of the radicals r**5 and r**6 is -c6 h4 -so2 -nh-r**7 , where r**7 is  see diagramm : ep0000336,p9,f2   see diagramm : ep0000336,p9,f3  or pyrimidin-2-yl, 4-methyl-pyrimidin-2-yl, 5-methyl-pyrimidin-2-yl, 5-isopropyl-pyrimidin-2-yl, 5-methoxy-pyrimidin-2-yl, 6-methoxy-pyridazin-3-yl, 3-methoxy-pyrazin-2-yl, 5-methyl-isoxazol-3-yl or 2-pyridinyl, or r**5 and r**6 together with the nitrogen to which they are bonded are a saturated heterocyclic ring of 5-7 members, which may contain an oxygen atom or the n-y group, where y is methyl, benzyl or phenyl, and their pharmacologically acceptable salts with acids conventionally used for this purpose. 
</ABSTRACT>
</TEXT>
</DOC>
